Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma.
Saved in:
| Title: | Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma. |
|---|---|
| Authors: | Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. daniel.landsburg@pennmedicine.upenn.edu., Musoke N; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Gentile C; Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Brooks TR; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Carter JS; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Thomas CJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Tomasulo EB; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Cook MR; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Morrissette JJD; Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Caimi PF; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Hill BT; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. |
| Source: | Leukemia [Leukemia] 2026 Mar; Vol. 40 (3), pp. 694-697. Date of Electronic Publication: 2026 Feb 17. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41703025 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Landsburg+DJ%22">Landsburg DJ</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. daniel.landsburg@pennmedicine.upenn.edu.<br /><searchLink fieldCode="AU" term="%22Musoke+N%22">Musoke N</searchLink>; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Gentile+C%22">Gentile C</searchLink>; Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+TR%22">Brooks TR</searchLink>; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Nasta+SD%22">Nasta SD</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Barta+SK%22">Barta SK</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Carter+JS%22">Carter JS</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chong+EA%22">Chong EA</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Svoboda+J%22">Svoboda J</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Schuster+SJ%22">Schuster SJ</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+CJ%22">Thomas CJ</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Tomasulo+EB%22">Tomasulo EB</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cook+MR%22">Cook MR</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Morrissette+JJD%22">Morrissette JJD</searchLink>; Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Caimi+PF%22">Caimi PF</searchLink>; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2026 Mar; Vol. 40 (3), pp. 694-697. <i>Date of Electronic Publication: </i>2026 Feb 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41703025 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-026-02870-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 694 Titles: – TitleFull: Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Landsburg DJ – PersonEntity: Name: NameFull: Musoke N – PersonEntity: Name: NameFull: Gentile C – PersonEntity: Name: NameFull: Brooks TR – PersonEntity: Name: NameFull: Nasta SD – PersonEntity: Name: NameFull: Barta SK – PersonEntity: Name: NameFull: Carter JS – PersonEntity: Name: NameFull: Chong EA – PersonEntity: Name: NameFull: Svoboda J – PersonEntity: Name: NameFull: Schuster SJ – PersonEntity: Name: NameFull: Thomas CJ – PersonEntity: Name: NameFull: Tomasulo EB – PersonEntity: Name: NameFull: Cook MR – PersonEntity: Name: NameFull: Morrissette JJD – PersonEntity: Name: NameFull: Caimi PF – PersonEntity: Name: NameFull: Hill BT IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 40 – Type: issue Value: 3 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |